作者: B.M. Ewenstein , C. Takemoto , I. Warrier , J. Lusher , P. Saidi
关键词:
摘要: To the Editor: Inhibitors to factor IX (fIX) develop in approximately 1.5% 3% of persons with severe hemophilia B and are commonly associated complete absence fIX antigen due large gene deletions or nonsense mutations.[1][1] The occurrence high-titer inhibitors severely